Asklepion Pharmaceuticals, LLC

Quick facts

Phase 3 pipeline

• Placebo of intravenous L-citrulline
  This is a placebo control (inert substance) used in clinical trials to compare against active intravenous L-citrulline treatment.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Asklepion Pharmaceuticals, LLC portfolio CI brief
• Asklepion Pharmaceuticals, LLC pipeline updates RSS